Login / Signup

Outcomes after SynCardia® temporary total artificial heart implantation: A 20-year single-center experience in 196 patients.

Artyom RazumovMelchior BurriArmin ZittermannDarko RadakovicVolker LauenrothSebastian V RojasHenrik FoxRené SchrammJan GummertMarcus-André DeutschMichiel Morshuis
Published in: Artificial organs (2024)
While high mortality rates persist among patients with biventricular failure, the SynCardia® TAH offers a viable interim solution for critically ill patients, particularly those who can be successfully bridged to heart transplantation.
Keyphrases